STEFANIE BAILEY: Open Payments
NPI 1619328069 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 28 payments from 6 companies in 2025. Trend: 2023 $723 · 2024 $505 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| Almatica Pharma LLC | 19 | $347 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: LOREEV XR, Auvelity, REXULTI, TRINTELLIX, FANAPT, INGREZZA.
Industry payments across WI — which companies pay providers there.
